Low expression of bcl-2 in Brca1-associated breast cancers (Q36691973)

15 August 2017

Low expression of bcl-2 in Brca1-associated breast cancers (English)

1 reference

15 August 2017

7

Vincent-Salomon A

1 reference

15 August 2017

Dominique Stoppa-Lyonnet

2

object named as

Stoppa-Lyonnet D

1 reference

15 August 2017

10

Sastre-Garau X

1 reference

15 August 2017

Freneaux P

1

1 reference

15 August 2017

Mouret E

3

1 reference

15 August 2017

Kambouchner M

4

1 reference

15 August 2017

Nicolas A

5

1 reference

15 August 2017

Zafrani B

6

1 reference

15 August 2017

Fourquet A

8

1 reference

15 August 2017

Magdelenat H

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

10

1 reference

15 August 2017

1318-1322

1 reference

BRCA1 and BRCA2 in breast cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Bcl-2 protein expression and long-term survival in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Prognostic value of bcl-2 expression in invasive breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

The molecular epidemiology of p53 gene mutations in human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

bcl-2 and apoptosis in lymph node positive breast carcinoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408784

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

5 September 2018

1 reference

12 December 2020

Histoprognostic grade in BRCA1-associated breast cancer

1 reference

12 December 2020

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

12 December 2020

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

12 December 2020

1 reference

12 December 2020

p53 mutations in BRCA1-associated familial breast cancer

1 reference

12 December 2020

Inherited BRCA2 mutation associated with high grade breast cancer

1 reference

12 December 2020

BRCA-associated breast cancer: absence of a characteristic immunophenotype

1 reference

12 December 2020

p53 mutations in BRCA1-associated familial breast cancer

1 reference

12 December 2020

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1438

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11044356

1 reference